Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on February 6, 2014. The filing serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2013. The actual financial data is contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not part of the input content.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the fourth quarter and full year 2013 were reported.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. It strictly references the existence of the press release containing this information.
Investor Verification Checklist
- Verify the correct registrant name is Fluidigm Corporation, as the request metadata incorrectly listed "Standard BioTools Inc."
- Locate and review Exhibit 99.1 (the press release dated February 6, 2014) to obtain actual revenue, earnings, and cash flow figures.
- Confirm the specific details of the fourth quarter and full-year 2013 performance in the external press release.
- Note that the information in this 8-K is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.